MedKoo Cat#: 205947 | Name: BMS-214662 free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BMS-214662 is a Farnesyltransferase inhibitor , is also a nonsedating benzodiazepine derivative with potential antineoplastic activity. BMS-214662 inhibits the enzyme farnesyltransferase and the post-translational farnesylation of number of proteins involved in signal transduction, which may result in the inhibition of Ras function and apoptosis in susceptible tumor cells. This agent may reverse the malignant phenotype of H-Ras-transformed cells and has been shown to be active against tumor cells with and without Ras mutations.

Chemical Structure

BMS-214662 free base
BMS-214662 free base
CAS#195987-41-8 (free base)

Theoretical Analysis

MedKoo Cat#: 205947

Name: BMS-214662 free base

CAS#: 195987-41-8 (free base)

Chemical Formula: C25H23N5O2S2

Exact Mass: 489.1293

Molecular Weight: 489.61

Elemental Analysis: C, 61.33; H, 4.74; N, 14.30; O, 6.54; S, 13.10

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
Synonym
BMS214662; BMS214662; BMS-214662; BMS-214662 free base;
IUPAC/Chemical Name
(R)-1-((1H-imidazol-5-yl)methyl)-3-benzyl-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonitrile
InChi Key
OLCWFLWEHWLBTO-HSZRJFAPSA-N
InChi Code
InChI=1S/C25H23N5O2S2/c26-13-20-8-9-24-21(11-20)15-30(34(31,32)25-7-4-10-33-25)23(12-19-5-2-1-3-6-19)17-29(24)16-22-14-27-18-28-22/h1-11,14,18,23H,12,15-17H2,(H,27,28)/t23-/m1/s1
SMILES Code
N#CC1=CC=C2N(CC3=CN=CN3)C[C@@H](CC4=CC=CC=C4)N(S(=O)(C5=CC=CS5)=O)CC2=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>5 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
        

Preparing Stock Solutions

The following data is based on the product molecular weight 489.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
 1: de Andrade CP, de Oliveira EC, Leal JS, de Almeida LL, de Castro LA, da Silva SC, Driemeier D. Report of outbreaks of classical scrapie in Dorper sheep and associated prion protein gene polymorphisms in affected flocks. Trop Anim Health Prod. 2015 May 21. [Epub ahead of print] PubMed PMID: 25995150. 2: Reis F, Kido RY, Mesquita JA, Oshima MM, Montenegro MA. Megalencephalic leukoencephalopathy with subcortical cysts (MLC) - a case with clinical and magnetic resonance imaging (MRI) dissociation. Arq Neuropsiquiatr. 2015 Feb;73(2):171-2. doi: 10.1590/0004-282X20140206. PubMed PMID: 25742591. 3: McGovern G, Martin S, Jeffrey M, Bellworthy SJ, Spiropoulos J, Green R, Lockey R, Vickery CM, Thurston L, Dexter G, Hawkins SA, González L. Influence of breed and genotype on the onset and distribution of infectivity and disease-associated prion protein in sheep following oral infection with the bovine spongiform encephalopathy agent. J Comp Pathol. 2015 Jan;152(1):28-40. doi: 10.1016/j.jcpa.2014.09.004. Epub 2014 Nov 27. PubMed PMID: 25435510. 4: Savarese LG, Ferreira-Neto GD, Herrero CF, Defino HL, Nogueira-Barbosa MH. Cauda equina redundant nerve roots are associated to the degree of spinal stenosis and to spondylolisthesis. Arq Neuropsiquiatr. 2014 Oct;72(10):782-7. PubMed PMID: 25337731. 5: Andrade-Silva SG, Caranti DA, Sallet JA, Leal LP, Leal AJ, Dâmaso AR. Age and gender may influence the results of Roux-en-Y gastric bypass? Metabolic syndrome parameters. Arq Gastroenterol. 2014 Jul-Sep;51(3):171-9. PubMed PMID: 25296075. 6: Greenlee JJ, Kunkle RA, Richt JA, Nicholson EM, Hamir AN. Lack of prion accumulation in lymphoid tissues of PRNP ARQ/ARR sheep intracranially inoculated with the agent of scrapie. PLoS One. 2014 Sep 18;9(9):e108029. doi: 10.1371/journal.pone.0108029. eCollection 2014. PubMed PMID: 25233232; PubMed Central PMCID: PMC4169493. 7: Secundo Junior JA, Santos MA, Faro GB, Soares CB, Silva AM, Secundo PF, Teixeira CK, Oliveira JL, Barreto Filho JA, Sousa AC. Left atrial volume index and prediction of events in acute coronary syndrome: Solar Registry. Arq Bras Cardiol. 2014 Oct;103(4):282-91. Epub 2014 Aug 13. English, Portuguese. Erratum in: Arq Bras Cardiol. 2014 Dec;103(6):546. PubMed PMID: 25119895; PubMed Central PMCID: PMC4206358. 8: Abreu JS, Lima JW, Diógenes TC, Siqueira JM, Pimentel NL, Gomes Neto PS, Abreu ME, Paes Júnior JN. Coronary flow velocity reserve during dobutamine stress echocardiography. Arq Bras Cardiol. 2014 Feb;102(2):134-42. Epub 2013 Dec 21. PubMed PMID: 24676368; PubMed Central PMCID: PMC3987342. 9: González L, Pitarch JL, Martin S, Thurston L, Simmons H, Acín C, Jeffrey M. Influence of polymorphisms in the prion protein gene on the pathogenesis and neuropathological phenotype of sheep scrapie after oral infection. J Comp Pathol. 2014 Jan;150(1):57-70. doi: 10.1016/j.jcpa.2013.10.001. Epub 2013 Oct 10. PubMed PMID: 24342584. 10: Dozza AL, Krymchantowski AV. Adherence to migraine treatment does not depend on the number of prescribed medications. Arq Neuropsiquiatr. 2013 Mar;71(3):171-3. PubMed PMID: 23563717.